BiotechTubeBiotechTube
Home/Polaryx Therapeutics/John Smith
JS

John Smith

Chief Financial Officer

Polaryx Therapeutics

Therapeutic Areas

Rare Neurological DiseasesLysosomal Storage DisordersNeurodegenerative Diseases

Polaryx Therapeutics Pipeline

DrugIndicationPhase
PLX-200CLN2 Batten Disease (Neuronal Ceroid Lipofuscinosis Type 2)Phase 1/2
PLX-100Lysosomal Storage DisordersPreclinical

Leadership Team at Polaryx Therapeutics

DS
Dr. Sung Yun Jung
Founder and Chief Executive Officer
DH
Dr. Hye Young Lee
Chief Scientific Officer
DS
Dr. Sarah Chen
Chief Medical Officer
MR
Michael Rodriguez
Vice President of Business Development
DR
Dr. Robert Kim
Vice President of Research
View full Polaryx Therapeutics profile